https://www.gosh.nhs.uk/news/the-important-role-of-data-science-in-accelerating-advancements-in-care-for-rare-diseases/
The important role of data science in accelerating advancements in care for rare diseases
20 Feb 2025, 4 p.m.
We are always looking for new ways to improve care for children and families. For many of young patients, especially those with rare or complex conditions, getting the right diagnosis and treatment can be a challenging journey. That’s where data science can make a real difference.
Finding answers faster with data science
One of the biggest challenges in rare diseases is getting an accurate diagnosis. Many families go through years of uncertainty before they find the right answers. By embracing developments in data science and new technologies, we hope to reduce the diagnostic odyssey (the long and difficult journey that many rare disease patients undertake to receive an accurate diagnosis and treatment) and give families the answers they need sooner.
Personalised treatments for every child
Every child is unique, and rare diseases often don't have a 'one-size-fits-all' solution, but data science is helping us develop more targeted treatments.
Predictive analytics can allow us to see how a child might respond to a particular medication, helping us choose the safest and most effective option. This means our patients could receive treatments tailored just for them.
The role of the GOSH DRIVE Unit
Our Digital Research, Informatics and Virtual Environments (DRIVE) unit is at the heart of this important work. As a leading centre for paediatric healthcare data innovation, DRIVE aims to harness the power of data and cutting-edge technology to enhance patient care, as well as to better support staff.
We know that by working together we can achieve so much more, and working with our industry partners such as Arcturis, Aridhia and Roche UK continues to play a significant part in our journey.
- Our electronic patient health records allow us to compare cases across up to 25 years of GOSH records and learn from previous experiences, making it easier to recognise rare conditions.
- By pioneering the use of AI, we are building tools that could further our understanding of rare diseases. For example, tools that can securely scan through reports to pull out important genomic data and combine this with other important clinical information for a variety of diseases.
- We are also developing multiple predictive Machine Learning tools to anticipate the needs of patient groups.
Driving research and innovation through our secure data environment
Our secure Data Research Environment (DRE), is a protected digital space designed to allow researchers to access and analyse sensitive data safely and responsibly.
The GOSH DRE is vital to our mission as it enables:
- Protection of patient privacy: All data is de-identified and stored securely, ensuring no unauthorised access.
- Safe research collaboration: Researchers across multiple hospitals and universities can work together on projects without downloading or transferring sensitive data.
- Powerful computing tools: A DRE provides access to advanced analytics, AI, and machine learning tools to accelerate discoveries.
- Faster and better insights: By providing a structured and compliant way to analyse data, we can turn information into real-world health improvements more efficiently.
We recently hit a big milestone, with 400 research projects being supported by our secure DRE. This is not only a testament to how far we have come on our digital journey, but also a real achievement for collaborative working between clinicians, researchers and data teams.
International collaborations
Rare diseases are often difficult to study because they individually affect so few people, but by working collaboratively with hospitals and researchers as part of international networks such as through the PHEMS project, we are developing new ways to securely share data between different hospitals. This can help researchers to learn more about these conditions and share insights without data ever being shared.
Rare Disease Day
28 February is Rare Disease Day, a global opportunity to raise awareness for people living with rare disease and celebrate advancements in care. You can find out more about rare diseases and how we are supporting Rare Disease Day 2025 https://www.gosh.nhs.uk/news/the-countdown-to-rare-disease-day-2025-is-on/
New research analyses key immune cell
A new study led by researchers at University College London Great Ormond Street Institute of Child Health has found that women have a higher proportion of key immune cells between puberty and menopause.
First patient treated with groundbreaking gene therapy trial
A baby boy born with a rare condition has become the first in the world to be treated with a new, potentially lifechanging, investigational gene therapy on a clinical trial at Great Ormond Street Hospital (GOSH).
Professor Darren Hargrave appointed NIHR Senior Investigator
We’re delighted to announce that Professor Darren Hargrave has been named as a NIHR Senior Investigator in this year’s prestigious awards list.
Reflecting on rare disease day 2025
Rare Disease Day is an international event which takes place annually on the last day of February. The date is chosen because in leap years it is February 29, the rarest date!